EOLS Evolus, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · evolus.com

7.740USD+4.88%Mkt Cap: 511.23M $P/E: —1d ago

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap511.23M USD

Enterprise Value607.09M USD

Revenue (TTM)316.49M USD

Gross Profit197.11M USD

Net Income (TTM)-51.64M USD

Revenue/Share4.86 USD

Last Price7.740 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees353

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)25.23

PEG—

EV/EBITDA-47.52

EV/Revenue1.92

P/S1.54

P/B-15.77

EPS (TTM)-0.53

EPS (Forward)0.29

52W Range

3.86071% of range9.310

52W High9.310 USD

52W Low3.860 USD

Profitability

Gross Margin66.33%

Oper. Margin-5.17%

EBITDA Margin-4.04%

Profit Margin-17.38%

ROE223.50%

ROA-22.86%

Growth

Revenue Growth21.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-42.27M USD

CapEx (TTM)8.45M USD

FCF Margin-0.57%

FCF Yield-0.36%

Net Debt119.63M USD

Net Debt/EBITDA-9.37

Balance Sheet

Debt/Equity-6.71

Current Ratio1.70

Quick Ratio1.09

Book Value/Sh-0.47 USD

Cash/Share0.68 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)15.00 USD

Upside (mean)+93.8%

Target Range12.00 USD – 20.00 USD

12.00+93.8% to mean20.00

# Analysts5

Ownership

Shares Out.66.05M

Float49.77M

Insiders11.25%

Institutions77.74%

Short Interest

Short Ratio5.8d

Short % Float8.48%

Short % Out.8.37%

Shares Short5.53M

Short (prev mo.)5.85M

Technical

SMA 507.884 (-1.8%)

SMA 2006.160 (+25.6%)

Beta1.34

S&P 52W Chg16.45%

Avg Vol (30d)812.10K

Avg Vol (10d)697.55K

Technical Indicators

RSI (14)48.3

MACD-0.0993

MACD Signal-0.0044

MACD Hist.-0.0949

BB Upper8.668 USD

BB Middle7.917 USD

BB Lower7.166 USD

BB Width18.98%

ATR (14)0.3930 USD

Vol Ratio (20d)0.76x